1495. Mpox Vaccine Immunity in People Living with HIV (PLWH) During The 2022 Mpox Outbreak in New York City

BACKGROUND: The WHO estimated that in 2022 49% of people affected by Mpox were PLWH. Due to initial vaccine shortage in 2022, a 1/5 dose of vaccine given intradermally (ID) was FDA-authorized (8/9/22). The ID regimen had never been evaluated in PLWH. Here we describe the characteristics, and IgG res...

Descripción completa

Detalles Bibliográficos
Autores principales: Kottkamp, Angelica C, Oom, Aaron, Wilson, Kesi K, Rettig, Stephanie, Frank, Olivia, Engelson, Celia, Davis, Tamia S, Noriega, Irma, Callahan, Jacqueline, Yip, Samantha, Youn, Heekoung, Wagner, Julia, Carmody, Ellie, Parameswaran, Lalitha, Tuen, Michael, Wilson, Jimmy P, Goins, Shelby J, Zhao, Lisa, Nweke, Samuel, Haiken, Sarah, Suman, Pamela, Dontino, Amanda, Rosen, Jennifer, Zucker, Jane R, Duerr, Ralf, Samanovic, Marie I, Mulligan, Mark J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678738/
http://dx.doi.org/10.1093/ofid/ofad500.1330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678738/
http://dx.doi.org/10.1093/ofid/ofad500.1330

Ejemplares similares